Finland Pharmaceuticals and Healthcare Report Q3 2013:Life Sciences Market Research Reports

Life Sciences Market Research Reports

Finland Pharmaceuticals and Healthcare Report Q3 2013 Jun 26th 2013, 00:00 BMI View: The Finnish government’s focus on drug pricing will significantly constrict drugmakers’ revenue-earning opportunities in 2013. In addition to the introduction of a reference price system in 2009, which led to a sharp drop in drug prices and consequently hit companies hard, as of February 2013, the government has enforced a 5% price cut on medicines not included in the reference price system. Headline Expenditure Projections: ? Pharmaceuticals: EUR2.69bn (US$3.42bn) in 2012 to EUR2.62bn (US$3.49bn) in 2013; -2.6% in local currency terms. ? Healthcare: EUR16.99bn (US$21.58bn) in 2012 to EUR17.44bn (US$23.20bn) in 2013; +2.7% in local currency terms and … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=104079. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/finland-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions